DCOY
Decoy Therapeutics Inc.
NASDAQ: DCOY · HEALTHCARE · BIOTECHNOLOGY
$5.15
-1.49% today
Updated 2026-06-05
Market cap
$2.94M
P/E ratio
0.05
P/S ratio
15.86x
EPS (TTM)
$106.79
Dividend yield
—
52W range
$4 – $180
Volume
0.3M
Decoy Therapeutics Inc. (DCOY) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-15.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+84.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-1.01 | $-1.81 | -79.2% | — | — |
| 2025-06-30 | $-1.02 | $-0.45 | +55.9% | — | — |
| 2025-03-31 | $-1.03 | $-1.03 | +0.0% | — | — |
| 2024-12-31 | $-0.74 | $-1.01 | -36.5% | — | — |
| 2024-09-30 | — | $-11.38 | — | — | — |
| 2024-06-30 | — | $-35.59 | — | — | — |
| 2024-03-31 | — | $-49.07 | — | — | — |
| 2023-12-31 | — | $-26.87 | — | — | — |
| 2023-09-30 | — | $-78.09 | — | — | — |
| 2023-06-30 | — | $-171.75 | — | — | — |
| 2023-03-31 | $-2.16 | $-2.23 | -3.2% | — | — |
| 2022-12-31 | — | $-339.25 | — | — | — |
Frequently asked questions
Has Decoy Therapeutics Inc. beaten earnings estimates?
Decoy Therapeutics Inc. has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, averaging a -15.0% surprise over the last 4. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.